Utility of a molecular prescreening program in advanced colorectal cancer for enrollment on biomarker-selected clinical trials(†)

BACKGROUND: Incorporation of multiple enrichment biomarkers into prospective clinical trials is an active area of investigation, but the factors that determine clinical trial enrollment following a molecular prescreening program have not been assessed. PATIENTS AND METHODS: Patients with 5-fluoroura...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Ann Oncol
Autori principali: Overman, M. J., Morris, V., Kee, B., Fogelman, D., Xiao, L., Eng, C., Dasari, A., Shroff, R., Mazard, T., Shaw, K., Vilar, E., Raghav, K., Shureiqi, I., Liang, L., Mills, G. B., Wolff, R. A., Hamilton, S., Meric-Bernstam, F., Abbruzzese, J., Morris, J., Maru, D., Kopetz, S.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2016
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6276928/
https://ncbi.nlm.nih.gov/pubmed/27045102
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdw073
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi